TBX3 and metabolic dysfunction-associated steatotic liver disease: Using MOSAICS, we identified loss-of-function mutations that induce clonal expansion only in the presence of metabolic dysfunction–associated steatotic liver disease (MASLD), and one of the most highly enriched mutations was in the transcription factor Tbx3 (11).